Navigation Links
Transition continues to impact Third Wave financials

Madison, Wis. -- Third Wave Technologies, a provider of molecular diagnostics solutions, reported losses in the second quarter in line with market expectations.

Third Wave reported total revenue of $5.8 million and a net loss of $5.5 million, or 13 cents per diluted share, for the quarter ended June 30, 2005, compared to total revenue of $12.6 mill......

Full article >>> uce the Invader chemistry platform and our new products to the market. Clinical labs do not switch easily. They conduct long, thorough assessments of new applications. However, once accepted, we believe it is difficult to be displaced."

Puisis also said he believed there are openings in the current marketplace, especially in the emerging pharmacogenetic field, in which medicine is specifi......

Full article >>>
'"/>

Source:wistechnology.com By Eric Kleefeld 07/27/05


Related biology technology :

1. Traveling stem cell show continues state tour
2. AT&T - BellSouth merger: Revestiture continues
3. Madison biotech continues its climb
4. Line between big pharma, big biotech continues to blur
5. Brady continues growth through Asian acquisition
6. Wisconsin giant continues to dominate the health care IT market
7. API Software continues expansion
8. Third Wave continues molecular diagnostic focus with new CEO
9. Corona Optical Systems continues to excite investors
10. Proposed telecom bill would have Katrina impact
11. Shades of gray: Business impacts of an aging workforce
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... , March 22, 2017  UBM and ... to announce their extended partnership and the third ... headlined by the 21 st Annual MassMEDIC ... taking place May 3-4, 2017. ... Technology Association (ADVAMED) President and CEO, Scott ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... New York , March 22, 2017 ... is largely fragmented, states a research report by Transparency ... S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted ... in 2015. The prominent players in this market are ... expand their product portfolio, which is likely to lead ...
(Date:3/22/2017)... /PRNewswire/ - FACIT announced a seed stage investment ... start-up created by FACIT focused on developing a ... with non-dilutive capital, achieves a targeted $3.0M financing ... Propellon to accelerate the nomination of a candidate ... entering a strategic partnership for clinical trials in ...
Breaking Biology Technology:
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis zum Jahr 2018 ... mehr als 50 Vertretern aus verschiedenen Branchen wurde aber klar, ... Prognose zu realisieren. ... Zu den Schwierigkeiten für Biobanking-Profis ... die Biobank, die Implementierung Zeit sparender Technologien, ein besseres ...
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
Breaking Biology News(10 mins):